Jackson Lindsey F, Mulligan Jennifer K, Justice Jeb M, Roper Steven N, Blatt Jason E, Lobo Brian C
Department of Otolaryngology, University of Florida, Gainesville, Florida, United States.
Department of Neurosurgery, University of Florida, Gainesville, Florida, United States.
J Neurol Surg B Skull Base. 2023 Nov 8;85(6):622-627. doi: 10.1055/s-0043-1775851. eCollection 2024 Dec.
The assessment of baseline olfactory function before endoscopic skull base surgery (ESBS) has been relatively limited compared with analysis before functional endoscopic sinus surgery (FESS). Our study addresses this knowledge gap, assessing preoperative olfactory function in ESBS and FESS and elucidating any differences. We conducted a retrospective review of patients undergoing anterior ESBS or FESS at a single institution between 2021 and 2022. We included 171 patients and compared their reported and measured preoperative olfactory function using the Sino-Nasal Outcome Test questionnaire and the 40-item University of Pennsylvania Smell Identification Test. Of the 171 patients included in this study, 30% of patients underwent ESBS and 70% underwent FESS. Of all patients, only 57% correctly reported their objective preoperative olfactory function. Of the 36 ESBS patients with measured preoperative hyposmia, only 31% correctly reported hyposmia, while 69% incorrectly reported normosmia. This distribution significantly differs ( < 0.0001) from the FESS subset (89 patients), with 64% correctly reporting hyposmia and 36% incorrectly reporting normosmia. Our analysis demonstrates higher than anticipated underreporting of preoperative hyposmia in patients undergoing ESBS as well as discrepancies between subjective and objective olfactory functions in the FESS population. The results highlight several gaps in knowledge regarding perioperative olfactory function that would be best examined with more thorough pre- and postoperative objective olfactory testing. This analysis demonstrates significant prognostic uncertainty for patients and providers and creates significant medicolegal uncertainty regarding the appropriate attribution of postoperative olfactory loss in cases without objective preoperative testing.
与功能性鼻内镜鼻窦手术(FESS)术前分析相比,内镜颅底手术(ESBS)术前嗅觉功能评估相对有限。我们的研究填补了这一知识空白,评估了ESBS和FESS患者的术前嗅觉功能,并阐明了两者之间的差异。
我们对2021年至2022年期间在单一机构接受前路ESBS或FESS的患者进行了回顾性研究。我们纳入了171例患者,并使用鼻窦结局测试问卷和40项宾夕法尼亚大学嗅觉识别测试比较了他们报告的和测量的术前嗅觉功能。
在本研究纳入的171例患者中,30%接受了ESBS,70%接受了FESS。在所有患者中,只有57%正确报告了他们术前的客观嗅觉功能。在36例术前测量为嗅觉减退的ESBS患者中,只有31%正确报告了嗅觉减退,而69%错误报告为嗅觉正常。这种分布与FESS亚组(89例患者)有显著差异( < 0.0001),FESS亚组中64%正确报告了嗅觉减退,36%错误报告为嗅觉正常。
我们的分析表明,接受ESBS的患者术前嗅觉减退的漏报率高于预期,并且FESS人群中主观和客观嗅觉功能之间存在差异。结果突出了围手术期嗅觉功能方面的几个知识空白,最好通过更全面的术前和术后客观嗅觉测试来进行研究。该分析表明,对于患者和医疗服务提供者而言存在显著的预后不确定性,并且在没有术前客观测试的情况下,对于术后嗅觉丧失的适当归因造成了重大的法医学不确定性。